CytomX Therapeutics, Inc. (CTMX) Revenue by Year
CytomX Therapeutics, Inc. generated $76.2M in revenue in fiscal year 2025. This represents a decrease of 44.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $18.3M in revenue. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters CytomX Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CTMX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
CTMX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More CytomX Therapeutics, Inc. financials
Frequently Asked Questions
What was CytomX Therapeutics, Inc.'s revenue in fiscal year 2025?
CytomX Therapeutics, Inc. generated $76.2M in revenue in fiscal year 2025.
How fast is CytomX Therapeutics, Inc.'s revenue growing?
CytomX Therapeutics, Inc. (CTMX) revenue fell by 44.8% year over year, from $138.1M to $76.2M in fiscal year 2025.
What is CytomX Therapeutics, Inc.'s revenue over the last twelve months?
CytomX Therapeutics, Inc. (CTMX) reported $18.3M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has CytomX Therapeutics, Inc.'s revenue changed over the years?
Across the 13 fiscal years this page covers, CytomX Therapeutics, Inc. (CTMX) revenue went from $888K in fiscal year 2013 to $76.2M in fiscal year 2025.
What was CytomX Therapeutics, Inc.'s revenue in the most recent quarter?
CytomX Therapeutics, Inc. (CTMX) reported $1.4M in revenue in Q2 2026. This represents a decrease of 92.4% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what CytomX Therapeutics, Inc. (CTMX) reported on that line in every period on record.